A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges

Нарративный обзор легочного заболевания, вызванного нетуберкулезными микобактериями: микробиология, эпидемиология, диагностика и проблемы лечения
Kamal A. Hamed, Glenn Tillotson
2023-11-02

diagnostic approachesepidemiologyguideline-based treatmentnontuberculous mycobacteriapulmonary disease
INTRODUCTION: Nontuberculous mycobacteria (NTM) are a diverse group of mycobacterial species that are ubiquitous in the environment. They are opportunistic pathogens that can cause a range of diseases, especially in individuals with underlying structural lung disease or compromised immune systems. AREAS COVERED: This paper provides an in-depth analysis of NTM infections, including microbiology, environmental sources and transmission pathways, risk factors for disease, epidemiology, clinical manifestations and diagnostic approaches, guideline-based treatment recommendations, drugs under development, and management challenges. EXPERT OPINION: Future approaches to the management of NTM pulmonary disease will require therapies that are well tolerated, can be taken for a shorter time period and perhaps less frequently, have few drug-drug interactions, and are active against the various strains of pathogens. As the numbers of infections increase, such therapies will be welcomed by clinicians and patients.
1
Diagnosis and management of NTM pulmonary disease remain challenging, requiring integration of clinical, epidemiological, microbiological, and guideline-based treatment considerations.
2
Future therapies should be better tolerated, shorter and potentially less frequent, have fewer drug interactions, and remain active against diverse NTM strains.
3
Increasing NTM infection rates underscore the need for improved treatment options that address limitations of current management.
4
Nontuberculous mycobacteria are environmentally ubiquitous opportunistic pathogens causing pulmonary disease, particularly in patients with structural lung disease or impaired immunity.
5
The review synthesizes NTM microbiology, environmental sources, transmission pathways, risk factors, epidemiology, clinical manifestations, diagnosis, treatment recommendations, emerging drugs, and management challenges.

nontuberculous mycobacterial pulmonary disease and its causative NTM pathogens

the microbiology, epidemiology, transmission, clinical manifestations, diagnosis, treatment, and management challenges of NTM pulmonary disease

Publication Details
Publication Date
2023-11-02
Journal
Publisher
ISSN
Cited by
44
Access Type
Author Information
Authors
Kamal A. Hamed
Glenn Tillotson
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%